ArticleCancer reports (Hoboken, N.J.)2026
Complete Response to Nivolumab-Relatlimab Following Progression of Invasive Sinonasal Mucosal Melanoma on First-Line Nivolumab-Ipilimumab: A Case Report.
Reema Patel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.